TACROLIMUS 0.1% IN PSEUDOCATALASE- tacrolimus 0.1% in pseudocatalase cream 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

TACROLIMUS 0.1% IN PSEUDOCATALASE

Directions for use

d

Sincerus Florida, LLC adverse reactions.

n

Active, inactive

d

NDC 72934-2174-2 / TACROLIMUS USP 0.1%. Cream 30gm

s

TACROLIMUS 0.1% IN PSEUDOCATALASE 
tacrolimus 0.1% in pseudocatalase cream
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-2174
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TACROLIMUS (UNII: WM0HAQ4WNM) (TACROLIMUS ANHYDROUS - UNII:Y5L2157C4J) TACROLIMUS ANHYDROUS0.1 g  in 100 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-2174-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/01/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/01/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-2174)

Revised: 4/2019
Document Id: 874b82c6-ef06-8ce2-e053-2a95a90a5695
Set id: 874b82c6-ef05-8ce2-e053-2a95a90a5695
Version: 1
Effective Time: 20190424
 
Sincerus Florida, LLC